Peer Review History

Original SubmissionOctober 15, 2020
Decision Letter - Manuel Fernández-Alcántara, Editor

PONE-D-20-32408

A Qualitative study to explore the experience of parents of newborns admitted to neonatal care unit in rural Rwanda

PLOS ONE

Dear Dr. Byiringiro,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Mar 01 2021 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.
  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.
  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols

We look forward to receiving your revised manuscript.

Kind regards,

Manuel Fernández-Alcántara, Ph.D.

Academic Editor

PLOS ONE

Additional Editor Comments :

The article present important and interesting data that will be useful for researchers and clinicians. However there are important methodological flaws that author should clarify to consider publication in PlosOne. Please take in consideration the commentaries of reviewer 2 and I also strongly recommend to use the COREQ checklist for reporting of qualitative studies. Please also justify and make a major revision of the results section of the manuscript.

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Please include additional information regarding the survey or questionnaire used in the study and ensure that you have provided sufficient details that others could replicate the analyses. For instance, if you developed a questionnaire as part of this study and it is not under a copyright more restrictive than CC-BY, please include a copy, in both the original language and English, as Supporting Information.

3. In your Methods section, please provide additional information about the participant recruitment method and the demographic details of your participants. Please ensure you have provided sufficient details to replicate the analyses such as:

- the recruitment date range (month and year)

- a description of any inclusion/exclusion criteria that were applied to participant recruitment

- a table of relevant demographic details

- a statement as to whether your sample can be considered representative of a larger population

- a description of how participants were recruited

- descriptions of where participants were recruited and where the research took place.

4. Please provide additional details regarding participant consent. In the ethics statement in the Methods and online submission information, please ensure that you have specified whether consent was informed.

5. We note that you have indicated that data from this study are available upon request. PLOS only allows data to be available upon request if there are legal or ethical restrictions on sharing data publicly. For information on unacceptable data access restrictions, please see http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions.

In your revised cover letter, please address the following prompts:

a) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially identifying or sensitive patient information) and who has imposed them (e.g., an ethics committee). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent.

b) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings as either Supporting Information files or to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. Please see http://www.bmj.com/content/340/bmj.c181.long for guidelines on how to de-identify and prepare clinical data for publication. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories.

We will update your Data Availability statement on your behalf to reflect the information you provide.

6. Your ethics statement should only appear in the Methods section of your manuscript. If your ethics statement is written in any section besides the Methods, please delete it from any other section.

7. Please include your tables as part of your main manuscript and remove the individual files. Please note that supplementary tables should be uploaded as separate "supporting information" files.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Partly

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: N/A

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: No

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: This study is very important nowadays. The new philosophy of care involving parents and families is expressed in this manuscript which aim was to determine the family environment, parental stressors in the parents of premature infants in NICU. The study is clear, well organized and results revealed that family environment and stress in parents of premature infants was at the moderate level. Authors focused in the healthcare team that must pay attention to parents preventing the adverse effects of stressors on parents and ultimately on their babies.

Educational and counseling interventions by NICU nurses improves parents' ability to use strategies to manage stress.

The authors should include in the list of abbreviations all abbreviations of the manuscript, namely PTSD

Reviewer #2: Design

This was not a phenomenological design – no theoretical underpinning of the study evidenced. Suggest that this is changed to a qualitative descriptive and contextual study. The design refers to semi-structured interviews, however in the abstract it states: “In-depth interviews

were conducted using a semi-structured guide”.

There is debate about the different types of interviews and how these are categorized. Without having access to the interview guide, it is not clear whether these were semi structured interviews using a pre-determined set of questions or in-depth interviews, with a broad opening question followed by sub questions or prompts. I suggest that this be changed to semi-structured interviews which is appropriate for this type of study.

Participants

Explain the purpose of the stratification of the sample. I assume this was to ensure maximum diversity. What is the rationale for the choice of 3 days in NCU?

Data collection

With more than one interviewer, how was data saturation determined? Was this at data analysis stage? Please clarify.

Data analysis

The authors state that a code book was created based on literature but provide no further substantiation of this process. It would appear that the analysis was deductive, not a phenomenological tradition.

Trustworthiness

Trustworthiness/rigor is not explicitly discussed. Please include this in the revision – e.g., confirmability, audit trail, transferability etc.

The authors should use the COREQ or similar criteria for reporting of qualitative studies.

Ethics

Very limited ethics information provided. Was what done to protect participants’ confidentiality and anonymity? How was risk to the vulnerable participants managed?

Results/findings

The four themes are presented but it is not clear how these emerged – an example of the subthemes and codes need to be provided as evidence of the process. Please explain health insurance in the Rwandan context. The four themes are descriptive, and appropriate to the aim of the study. They are supported by fairly long quotes, but insufficient ‘thick description” is provided. It is preferable to add the participant number as well as description. This section needs rewriting to provide evidence of depth of analysis.

Discussion

Basic discussion covers the most relevant aspect but fails to really engage with literature

Limitations

No limitations included

Conclusion

Recommendations are general and not linked directly to experiences. An example of this is the issue of financial stress and the accompanying recommendations. The is no doubt that the experience of struggling to afford care is a very real one for parents. An explanation of the health insurance structure in Rwanda is needed to contextualize this recommendation

Some language issues which need to be corrected and one or two typographical errors.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Revision 1

Dear PlosONE Editor,

We appreciated you and the reviewers taking the time to thoroughly review this manuscript and provide us the useful feedback. Please find the point-to-point feedback to the comments made on the manuscript.

Comments are in black and the feedback in a different color.

The article present important and interesting data that will be useful for researchers and clinicians. However there are important methodological flaws that author should clarify to consider publication in PlosOne. Please take in consideration the commentaries of reviewer 2 and I also strongly recommend to use the COREQ checklist for reporting of qualitative studies. Please also justify and make a major revision of the results section of the manuscript.

Thank you for this feedback. We have included the COREQ checklist (on the last page of this document) with our response to comments. Other feedback to the comments can be found down below.

1.Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

We have updated the formatting throughout the manuscript to comply with the guidelines of PLOS ONE.

2.Please include additional information regarding the survey or questionnaire used in the study and ensure that you have provided sufficient details that others could replicate the analyses. For instance, if you developed a questionnaire as part of this study and it is not under a copyright more restrictive than CC-BY, please include a copy, in both the original language and English, as Supporting Information.

A semi-structured in-depth interview guide was developed for this study. We have attached the Kinyarwanda (the local language) and English versions of the semi-structured interview guide as a supplementary material.

3.In your Methods section, please provide additional information about the participant recruitment method and the demographic details of your participants. Please ensure you have provided sufficient details to replicate the analyses such as:

- the recruitment date range (month and year)

- a description of any inclusion/exclusion criteria that were applied to participant recruitment

- a table of relevant demographic details

- a statement as to whether your sample can be considered representative of a larger population

- a description of how participants were recruited

- descriptions of where participants were recruited and where the research took place.

a.Thank you for the suggestion. We have added the recruitment date and inclusion and exclusion criteria in our methodology section as recommended. Now it read as (p.8):

Parents or primary caregivers of neonates discharged from the NCU between September 2018 and January 2019 (three months prior to data collection) were included in the study. To ensure that parents and caregivers had been amply exposed to the NCU experience, we only included those whose newborns were admitted to the NCU for at least three days. While some mothers and caregivers were aged below 18 years, we excluded them since their experience tends to be unique because of stigma associated with teenage pregnancy in Rwanda [31]. The acquisition of consent for the participants aged below 18 is additionally different. To ensure diversity and a mix of experiences, we purposively stratified the samples by distance (living within and more than 1-hour walking distance from the facility), by admitting diagnosis (prematurity and other reasons), and outcome (died or alive at discharge).

b.We have also inserted a paragraph on recruitment procedure to describe how and where participants were recruited (P. 9):

The recruitment took place between December 2018 and January 2019. After acquiring the approval to access data from Ruli District Hospital leadership, we made the list of eligible potential participants and their geographical locations from the NCU registry. We contacted the nearby Community Health Worker (CHW) to request permission on our behalf and book us an appointment to the potential participants’ homes. On the appointment date, the interviewer was accompanied by the CHW to the potential participant’s home which is where the data collection took place.

c. We have included the table of demographics

d.We have made clear the issue of representativeness among our limitations. (p.25):

This study has some limitations. Most respondents in our study were women, and insights from fathers were relatively limited. The current study was conducted in a district hospital that receives support from a few non-government organizations. Not all Rwandan hospitals receive such support, thus the findings may not be generalizable to other Rwandan health facilities.

4.Please provide additional details regarding participant consent. In the ethics statement in the Methods and online submission information, please ensure that you have specified whether consent was informed.

We have inserted the consent process in the data collection tool and procedure section, now it reads as (P. 9):

The study was approved by the Rwanda National Ethics Committee (No. 107/RNEC/2019) and the Institutional Review Board for the University of Global Health Equity. Ruli

District Hospital provided approval for NCU data access and participants signed informed consent prior to the beginning of the interviews. To protect the participants’

confidentiality, we de-identified all quotes included in the results by removing the names, and details that could lead to identify the individual participant or their healthcare

provider.

5.We note that you have indicated that data from this study are available upon request. PLOS only allows data to be available upon request if there are legal or ethical restrictions on sharing data publicly. For information on unacceptable data access restrictions, please see http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions.

In your revised cover letter, please address the following prompts:

a)If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially identifying or sensitive patient information) and who has imposed them (e.g., an ethics committee). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent.

b)If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings as either Supporting Information files or to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. Please see http://www.bmj.com/content/340/bmj.c181.long for guidelines on how to de-identify and prepare clinical data for publication. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories. We will update your Data Availability statement on your behalf to reflect the information you provide.

The interview transcripts are all available should they be needed.

6.Your ethics statement should only appear in the Methods section of your manuscript. If your ethics statement is written in any section besides the Methods, please delete it from any other section.

The ethics statement is in the method section (P.9).

The study was approved by the Rwanda National Ethics Committee (No. 107/RNEC/2019) and the Institutional Review Board for the University of Global Health Equity. Ruli District Hospital provided approval for NCU data access and participants signed informed consent prior to the beginning of the interviews. To protect the participants’ confidentiality, we utilized participant numbers in the transcripts instead of their names, and we de-identified all quotes included in the results by removing details that could lead to the recognition of the individual participant or their healthcare provider.

7.Please include your tables as part of your main manuscript and remove the individual files. Please note that supplementary tables should be uploaded as separate "supporting information" files.

We have placed all of the tables within the text where they are referenced.

Decision Letter - Manuel Fernández-Alcántara, Editor

PONE-D-20-32408R1

A qualitative study to explore the experience of parents of newborns admitted to neonatal care unit in rural Rwanda

PLOS ONE

Dear Dr. Byiringiro,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Authors have improved the original manuscript. However, further language editing of the manuscript is required. Please include in the data analysis section a discussion about rigor and add the COREQ checklist as a file for reviewers. After these minor revisions the article could be published in PlosOne.

Please submit your revised manuscript by May 28 2021 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.
  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.
  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Manuel Fernández-Alcántara, Ph.D.

Academic Editor

PLOS ONE

Journal Requirements:

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

Reviewer #2: (No Response)

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Partly

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: N/A

Reviewer #2: N/A

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: The manuscript is well written, in a standard English, methods well designed, and the data support the conclusions.

Reviewer #2: Overall the paper has been much improved. It still requires further language editing.Trustworthiness/rigor is still not discussed. I could not find the COREQ list.The authors have still written from a quantitative perspective - e.g. they refer to generalisability which would not apply in a small qualitative study.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Attachments
Attachment
Submitted filename: PONE-D-20-32408_R1_reviewer comments.pdf
Revision 2

Dear Editor,

We have addressed the comments from you and the reviewers as follows:

• Reviewer #2: Overall the paper has been much improved. It still requires further language editing. Trustworthiness/rigor is still not discussed. I could not find the COREQ list.The authors have still written from a quantitative perspective - e.g. they refer to generalisability which would not apply in a small qualitative study.

o We added the rigor/trustworthiness statements in both the analysis and data collection sections.

o We added the COREQ checklist in the supplementary files

o We changed the generalizability to transferability of the findings

o We did the language editing according to the recommendations given by the editor

• Additional changes

o We removed the ethics statement from the declaration section.

o To answer all relevant questions asked by the COREQ, we added the average duration of interviews under the results section,

o We included a statement which explains why mothers reported tiredness looking after their babies day and night – according to policy at the study site on page 16

o We did language editing on page 25 to clarify why patients still suffer the out of pocket burden while covered by the Community Based Health Insurance.

o Reviewed the references to ensure they are all accessible

Attachments
Attachment
Submitted filename: Response to Reviewers.docx
Decision Letter - Manuel Fernández-Alcántara, Editor

A qualitative study to explore the experience of parents of newborns admitted to neonatal care unit in rural Rwanda

PONE-D-20-32408R2

Dear Dr. Byiringiro,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Manuel Fernández-Alcántara, Ph.D.

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Formally Accepted
Acceptance Letter - Manuel Fernández-Alcántara, Editor

PONE-D-20-32408R2

A qualitative study to explore the experience of parents of newborns admitted to neonatal care unit in rural Rwanda

Dear Dr. Byiringiro:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Manuel Fernández-Alcántara

Academic Editor

PLOS ONE

Open letter on the publication of peer review reports

PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.

We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.

Learn more at ASAPbio .